Andrew Pitts - May 2, 2025 Biohaven secures $600M investment to advance life-changing therapies, including for spinocerebellar ataxia We extend a big congratulations to our client, Biohaven Ltd., on recently entering into an ...
Andrew Pitts - October 4, 2022 A patent attorney, a dog and meaning in the job 4 October 2022 is World Animal Day and we can reflect on how the strong bond with our canine ...
Andrew Pitts - August 10, 2021 A new referral to the EPO’s Enlarged Board of Appeal is plausible Despite not having any express legislative basis in the European Patent Convention, plausibility ...
Andrew Pitts - April 24, 2020 Governments look to protect companies from IP enforcement during the coronavirus (COVID-19) pandemic A large effort is underway globally to ensure that there are enough mechanical ventilators ...
Andrew Pitts - April 3, 2020 Patent infringement during a national emergency: a Coronavirus (COVID-19) perspective Recent interesting reports highlight an emerging practice borne out of necessity in which medical ...
Andrew Pitts - November 6, 2019 Coffee capsules: greener grounds Large consumer companies are increasingly focusing on reworking their consumable products to be ...
Andrew Pitts - October 16, 2019 Infecting the infection to tackle the rise in chemical antibiotic resistance In previous blogs we have highlighted how certain families of bacteria are highly resistant to ...
